Monitoring Virologic Responses to Antiretroviral Therapy in HIV-Infected Adults in Kenya: Evaluation of a Low-Cost Viral Load Assay

被引:19
作者
Sivapalasingam, Sumathi
Wangechi, Beatrice
Marshed, Fatuma
Laverty, Maura
Essajee, Shaffiq
Holzman, Robert S.
Valentine, Fred
机构
[1] Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, NY
[2] Bomu Medical Centre, Mombasa
[3] Division of Infectious Diseases, Department of Pediatrics, New York University School of Medicine, New York, NY
[4] Department of Environmental Medicine and Biostatistics, New York University School of Medicine, New York, NY
[5] Department of Microbiology, New York University School of Medicine, New York, NY
来源
PLOS ONE | 2009年 / 4卷 / 08期
关键词
RESOURCE-LIMITED SETTINGS; FIXED-DOSE COMBINATION; CD4 CELL COUNT; ADHERENCE; FAILURE; STRATEGIES; OUTCOMES; SUPPRESSION; PREDICTORS; RESISTANCE;
D O I
10.1371/journal.pone.0006828
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: A key advantage of monitoring HIV viral load (VL) in persons receiving antiretroviral therapy (ART) is the ability to detect virologic failure before clinical deterioration or resistance occurs. Detection of virologic failure will help clarify the need for enhanced adherence counseling or a change to second-line therapy. Low-cost, locally performable alternates to expensive VL assays are needed where resources are limited. Methodology/Principal Findings: We monitored the response to 48-week ART in 100 treatment-naive Kenyan adults using a low-cost VL measurement, the Cavidi reverse transcriptase (RT) assay and gold-standard assays, Roche RNA PCR and Bayer Versant HIV-1 RNA (bDNA) assays. In Altman-Bland plots, the mean difference in viral loads between the three assays was small (< 0.5 log(10) copies/mL). However, the limits of agreement between the methods exceeded the biologically relevant change of 0.5 log copies/ml. Therefore, the RT assay cannot be used interchangeably with the other assays to monitor individual patients. The RT assay was 100% sensitive in detecting viral loads of >= 400 copies/ml compared to gold-standard assays. After 24 weeks of treatment, viral load measured by the RT assay was undetectable in 95% of 65 patients with undetectable RNA PCR VL (< 400 copies/ml), 90% of 67 patients with undetectable bDNA VL, and 96% of 57 patients with undetectable VL in both RNA PCR and bDNA assays. The negative predictive value of the RT assay was 100% compared to either assay; the positive predictive value was 86% compared to RNA PCR and 70% compared to bDNA. Conclusion: The RT assay compared well with gold standard assays. Our study highlights the importance of not interchanging viral load assays when monitoring an individual patient. Furthermore, the RT assay may be limited by low positive predictive values when used in populations with low prevalence of virologic failure.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] [Anonymous], 2008, UN ACC SCAL PRIOR HI
  • [2] [Anonymous], 2006, ANT THER HIV INF AD
  • [3] Cost-effectiveness of HIV monitoring strategies in resource-limited settings - A Southern African analysis
    Bendavid, Eran
    Young, Sean D.
    Katzenstein, David A.
    Bayoumi, Ahmed M.
    Sanders, Gillian D.
    Owens, Douglas K.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (17) : 1910 - 1918
  • [4] The cost effectiveness of antiretroviral treatment strategies in resource-limited settings
    Bishai, David
    Colchero, Arantxa
    Durack, David T.
    [J]. AIDS, 2007, 21 (10) : 1333 - 1340
  • [5] Diagnostic virologic accuracy of CD4 cell count increase for response after initiating highly active antiretroviral therapy
    Bisson, Gregory P.
    Gross, Robert
    Strom, Jordan B.
    Rollins, Caitlin
    Bellamy, Scarlett
    Weinstein, Rachel
    Friedmand, Harvey
    Dickinson, Diana
    Frank, Ian
    Strom, Brian L.
    Gaolathe, Tendani
    Ndwapi, Ndwapi
    [J]. AIDS, 2006, 20 (12) : 1613 - 1619
  • [6] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [7] HIV viral load monitoring in resource-limited regions: Optional or necessary?
    Calmy, Alexandra
    Ford, Nathan
    Hirschel, Bernard
    Reynolds, Steven J.
    Lynen, Lut
    Goemaere, Eric
    de la Vega, Felipe Garcia
    Perrin, Luc
    Rodriguez, William
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) : 128 - 134
  • [8] Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
    Coetzee, D
    Hildebrand, K
    Boulle, A
    Maartens, G
    Louis, F
    Labatala, V
    Reuter, H
    Ntwana, N
    Goemaere, E
    [J]. AIDS, 2004, 18 (06) : 887 - 895
  • [9] A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
    Collins, ML
    Irvine, B
    Tyner, D
    Fine, E
    Zayati, C
    Chang, CA
    Horn, T
    Ahle, D
    Detmer, J
    Shen, LP
    Kolberg, J
    Bushnell, S
    Urdea, MS
    Ho, DD
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (15) : 2979 - 2984
  • [10] Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor Monitor version 1.5
    Elbeik, T
    Charlebois, E
    Nassos, P
    Kahn, J
    Hecht, FM
    Yajko, D
    Ng, V
    Hadley, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) : 1113 - 1120